Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents

Author： de Vries P. Singer J.W.

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.28, Iss.8, 2000-08, pp. : 916-923

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hematopoietic stem cells and other hematopoietic cells show broad resistance to chemotherapeutic agents in vivo when overexpressing bcl-2

By Domen J. Weissman I.L.

Experimental Hematology, Vol. 31, Iss. 7, 2003-07 ,pp. : 631-639

Elsevier

Access to resources Recommend Favorite

Ex Vivo Expansion of Primitive Murine Hematopoietic Progenitor Cells on Porcine Endothelial Cells

By Davis T.A. Lee K.P.

Transplantation Proceedings, Vol. 29, Iss. 4, 1997-06 ,pp. : 2005-2005

Elsevier

Access to resources Recommend Favorite

Homing and engraftment defects in ex vivo expanded murine hematopoietic cells are associated with downregulation of 1 integrin

By Szilvassy S.J. Meyerrose T.E. Ragland P.L. Grimes B.

Experimental Hematology, Vol. 29, Iss. 12, 2001-12 ,pp. : 1494-1502

Elsevier

Access to resources Recommend Favorite

Ex vivo expansion of human hematopoietic stem cells

By Nakahata Tatsutoshi

International Journal of Hematology, Vol. 73, Iss. 1, 2001-01 ,pp. : 6-13

Springer Publishing Company

Access to resources Recommend Favorite

Hsp90 inhibitors as novel cancer chemotherapeutic agents

By Neckers L.

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite